"Ethylene Glycols" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An ethylene compound with two hydroxy groups (-OH) located on adjacent carbons. They are viscous and colorless liquids. Some are used as anesthetics or hypnotics. However, the class is best known for their use as a coolant or antifreeze.
| Descriptor ID |
D005026
|
| MeSH Number(s) |
D02.033.455.250
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Ethylene Glycols".
Below are MeSH descriptors whose meaning is more specific than "Ethylene Glycols".
This graph shows the total number of publications written about "Ethylene Glycols" by people in this website by year, and whether "Ethylene Glycols" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2008 | 0 | 2 | 2 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 1 | 2 |
| 2012 | 2 | 2 | 4 |
| 2013 | 1 | 5 | 6 |
| 2014 | 5 | 2 | 7 |
| 2015 | 3 | 2 | 5 |
| 2016 | 1 | 8 | 9 |
| 2017 | 1 | 6 | 7 |
| 2018 | 1 | 4 | 5 |
| 2019 | 1 | 2 | 3 |
| 2020 | 0 | 3 | 3 |
| 2021 | 2 | 4 | 6 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 6 | 6 |
| 2025 | 0 | 1 | 1 |
Below are the most recent publications written about "Ethylene Glycols" by people in Profiles.
-
The striatum is an early, accurate indicator of amyloid burden using [11C]PiB in Down syndrome: Comparison of two radiotracers. Alzheimers Dement. 2025 Apr; 21(4):e70141.
-
Cerebral perfusion and amyloidosis in the oldest-old. Alzheimers Dement. 2024 Dec; 20(12):9068-9075.
-
Associations of Amyloid Burden, White Matter Hyperintensities, and Hippocampal Volume With Cognitive Trajectories in the 90+ Study. Neurology. 2024 Aug 13; 103(3):e209665.
-
Safety Profile of a Cognitively Unimpaired Older Population with Elevated Cerebral Amyloid in a 4.5-Year Clinical Trial. J Prev Alzheimers Dis. 2024; 11(4):857-868.
-
Longitudinal Trajectories of the Cognitive Function Index in the A4 Study. J Prev Alzheimers Dis. 2024; 11(4):838-845.
-
Relationship between Plasma P-Tau217 and Amyloid PET in Racial and Ethnic Underrepresented Groups (RE-URG) Compared with Non RE-URG in LEARN and A4. J Prev Alzheimers Dis. 2024; 11(4):831-837.
-
Characterizing Clinical Progression in Cognitively Unimpaired Older Individuals with Brain Amyloid: Results from the A4 Study. J Prev Alzheimers Dis. 2024; 11(4):814-822.
-
Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2023 07; 50(9):2669-2682.
-
Symptomatic Diethylene Glycol Ingestion Successfully Treated with Fomepizole Monotherapy. J Emerg Med. 2022 07; 63(1):58-61.
-
Association of Sleep and β-Amyloid Pathology Among Older Cognitively Unimpaired Adults. JAMA Netw Open. 2021 07 01; 4(7):e2117573.